Sourav Mukherjee

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Locally Advanced

Chemotherapy Induced

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)